These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1622637)

  • 21. Randomized trial of cyclophosphamide, doxorubicin, and 5-fluorouracil alone or alternating with a "cycle active" non-cross-resistant combination in women with visceral metastatic breast cancer: a Southeastern Cancer Study Group project.
    Vogel CL; Smalley RV; Raney M; Krauss S; Carpenter J; Velez-Garcia E; Fishkin E; Raab S; Moore MR; Stagg M
    J Clin Oncol; 1984 Jun; 2(6):643-51. PubMed ID: 6374057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The expanding role of epirubicin in the treatment of breast cancer.
    Glück S
    Cancer Control; 2002; 9(2 Suppl):16-27. PubMed ID: 11965227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary chemotherapy for resectable breast cancer.
    Bonadonna G; Veronesi U; Brambilla C; Ferrari L; Passoni P; Coopmans de Yoldi GF; Luini A; Greco M; Valagussa P
    Recent Results Cancer Res; 1993; 127():113-7. PubMed ID: 8502807
    [No Abstract]   [Full Text] [Related]  

  • 24. Accelerated-intensified cyclophosphamide, epirubicin, and fluorouracil (CEF) compared with standard CEF in metastatic breast cancer patients: results of a multicenter, randomized phase III study of the Italian Gruppo Oncologico Nord-Ouest-Mammella Inter Gruppo Group.
    Del Mastro L; Venturini M; Lionetto R; Carnino F; Guarneri D; Gallo L; Contu A; Pronzato P; Vesentini L; Bergaglio M; Comis S; Rosso R
    J Clin Oncol; 2001 Apr; 19(8):2213-21. PubMed ID: 11304774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: results of a randomized trial. The International Collaborative Cancer Group.
    Coombes RC; Bliss JM; Wils J; Morvan F; Espié M; Amadori D; Gambrosier P; Richards M; Aapro M; Villar-Grimalt A; McArdle C; Pérez-López FR; Vassilopoulos P; Ferreira EP; Chilvers CE; Coombes G; Woods EM; Marty M
    J Clin Oncol; 1996 Jan; 14(1):35-45. PubMed ID: 8558217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations.
    Petru E; Schmähl D
    Wien Klin Wochenschr; 1986 Dec; 98(23):790-7. PubMed ID: 3811371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination chemotherapy of breast cancer.
    Cooper RG
    Mt Sinai J Med; 1985 Jun; 52(6):443-6. PubMed ID: 3875023
    [No Abstract]   [Full Text] [Related]  

  • 28. Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer.
    Içli F; Günel N; Dinçol D; Karaoğuz H; Demirkazik A
    J Surg Oncol; 1992 Aug; 50(4):251-3. PubMed ID: 1640710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Epirubicin in combination chemotherapy of metastasized breast cancer (VEC) and advanced ovarian cancer (PEC)].
    Christmann D
    Onkologie; 1986 Aug; 9 Suppl 1():11-2. PubMed ID: 3528966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.
    Levine MN; Pritchard KI; Bramwell VH; Shepherd LE; Tu D; Paul N;
    J Clin Oncol; 2005 Aug; 23(22):5166-70. PubMed ID: 16051958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adriamycin, dibromodulcitol, and mitomycin combination chemotherapy for patients with metastatic breast carcinoma previously treated with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone.
    Pinnamaneni K; Yap HY; Buzdar AU; Distefano A; Blumenschein GR
    Cancer; 1984 May; 53(9):1841-4. PubMed ID: 6546706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The response to further chemotherapy in patients with carcinoma of the breast who progressed while receiving adjuvant therapy.
    Morris DM; Elias EG; Didolkar MS; Brown SD
    J Surg Oncol; 1985 Jul; 29(3):154-7. PubMed ID: 3001423
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Three new active cisplatin-containing combinations in the neoadjuvant treatment of locally advanced and locally recurrent breast carcinoma: a randomized phase II trial.
    Cocconi G; Bisagni G; Ceci G; Di Blasio B; De Lisi V; Passalacqua R; Zadro A; Boni C; Morandi P; Savoldi L
    Breast Cancer Res Treat; 1999 Jul; 56(2):125-32. PubMed ID: 10573105
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
    J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
    Theriault RL; Hortobagyi GN; Kau SW; Holmes FA; Hug V; Fraschini G; Jabboury K; Buzdar AU
    Cancer; 1988 Nov; 62(10):2105-10. PubMed ID: 3179923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of prior adjuvant chemotherapy on survival in metastatic breast cancer.
    Ahmann FR; Jones SE; Moon TE
    J Surg Oncol; 1988 Feb; 37(2):116-22. PubMed ID: 3343839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin versus methotrexate both combined with cyclophosphamide, 5-fluorouracil and tamoxifen in postmenopausal patients with advanced breast cancer--a randomised study with more than 10 years follow-up from the Danish Breast Cancer Cooperative Group. Danish Breast Cancer Cooperative Group (DBCG).
    Andersson M; Madsen EL; Overgaard M; Rose C; Dombernowsky P; Mouridsen HT
    Eur J Cancer; 1999 Jan; 35(1):39-46. PubMed ID: 10211086
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized trials of high dose chemotherapy for breast cancer.
    Antman KH
    Biochim Biophys Acta; 2001 Mar; 1471(3):M89-98. PubMed ID: 11250065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose, brief duration, multiagent chemotherapy for metastatic breast cancer.
    Lamar RE; Greco FA; Johnson DH; Murphy PB; Hainsworth JD
    Cancer; 1994 Apr; 73(7):1842-8. PubMed ID: 8137208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.
    Joensuu H; Kellokumpu-Lehtinen PL; Huovinen R; Jukkola-Vuorinen A; Tanner M; Kokko R; Ahlgren J; Auvinen P; Paija O; Helle L; Villman K; Nyandoto P; Nilsson G; Pajunen M; Asola R; Poikonen P; Leinonen M; Kataja V; Bono P; Lindman H
    J Clin Oncol; 2012 Jan; 30(1):11-8. PubMed ID: 22105826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.